title: Does papaverine cause endothelial injury in clinically relevant doses?
authors.forename: S
authors.initials: S
authors.lastname: Joshi
authors.forename: W L
authors.initials: WL
authors.lastname: Young
authors.forename: J
authors.initials: J
authors.lastname: Pile-Spellman
mesh_terms: D000818:Animals; D001921:Brain / Q000098:blood supply*; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D007261:Infusions, Intra-Arterial; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D010208:Papaverine / Q000008:administration & dosage / Q000009:adverse effects*; D051381:Rats; D012307:Risk Factors; D013345:Subarachnoid Hemorrhage / Q000150:complications; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014665:Vasodilator Agents; D010208:Papaverine